Bioventus (BVS) Cash from Operations (2020 - 2026)
Bioventus' (BVS) quarterly Cash from Operations came in at 8934000.0 in Q1 2026, up 146.22% YoY from 3628522.44 in Q1 2025, and down 76.47% on a QoQ basis from 37968000.0 in Q4 2025.
Bioventus (BVS) Cash from Operations (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of Cash from Operations data on file, last reported at 8934000.0 in Q1 2026.
- Quarterly Cash from Operations rose 146.22% year-over-year to 8934000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 102938000.0 (up 304.17% YoY) and the FY2025 annual result came in at 74673000.0, up 92.48% from the prior year.
- Cash from Operations slipped to 8934000.0 in Q1 2026, from 37968000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 37968000.0 in Q4 2025 to a low of 21019000.0 in Q2 2022.
- A 5-year average of 7306411.76 and a median of 8934000.0 in 2026 frame the typical range for Cash from Operations.
- The widest YoY moves for Cash from Operations: up 267.3% in 2023, down 6735.44% in 2023.
- Tracing BVS's Cash from Operations over 5 years: stood at 4385000.0 in 2022, then surged by 136.58% to 10374000.0 in 2023, then soared by 86.25% to 19322000.0 in 2024, then soared by 96.5% to 37968000.0 in 2025, then tumbled by 76.47% to 8934000.0 in 2026.
- The last three Cash from Operations figures came in at 8934000.0 (Q1 2026), 37968000.0 (Q4 2025), and 30098000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.26 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 651.90 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 269.20 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 168.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 437.05 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 367.10 Mn |
| 10 | Bioventus | 972.56 Mn | 943.11 Mn | 105.67 Mn | 19.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 19.87 Mn |
| Jun 27, 2026 | 19.87 Mn |
| Mar 28, 2026 | 8.93 Mn |
| Mar 28, 2026 | 8.93 Mn |
| Dec 31, 2025 | 37.97 Mn |
| Dec 31, 2025 | 37.97 Mn |
| Sep 27, 2025 | 30.10 Mn |
| Sep 27, 2025 | 30.10 Mn |
| Jun 28, 2025 | 25.94 Mn |
| Jun 28, 2025 | 25.94 Mn |
| Mar 29, 2025 | -19.33 Mn |
| Mar 29, 2025 | -19.33 Mn |
| Dec 31, 2024 | 19.32 Mn |
| Dec 31, 2024 | 19.32 Mn |
| Sep 28, 2024 | 10.32 Mn |
| Sep 28, 2024 | 10.32 Mn |
| Jun 29, 2024 | 15.16 Mn |
| Jun 29, 2024 | 15.16 Mn |
| Mar 30, 2024 | -6.01 Mn |
| Mar 30, 2024 | -6.01 Mn |